MyFinsight
Home
Blog
About
Contact
ctor: the balance sheet
Download
Download image
In-process research and
development
$73,400,000
Prepaid expenses
$1,331,280
Inventory
$22,286,693
Cash and cash
equivalents
$3,924,908
Total other assets
$73,400,000
Total current assets
$27,542,881
Total assets
$100,942,881
Total liabilities and
stockholders equity
$100,942,881
Total stockholders
equity
$44,866,231
Total liabilities
$56,076,650
Accumulated deficit
-$64,039,956
Additional paid-in capital
$108,897,836
Note payable to
related party-Related...
$3,800,111
Deferred tax liability
$2,784,960
Total current
liabilities
$49,491,579
Common stock - 0.0001
par value...
$8,351
Due to related
party-Related Party
$9,513,771
Accrued expenses
$4,093,124
License payable
$22,650,000
Accounts payable
$13,234,684
Back
Back
Balance Sheet
source: myfinsight.com
CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC. (CTOR)